Oral erythromycin is ineffective in the treatment of pityriasis rosea.

Abstract

Both groups were comparable with regard to sex, age, and mean duration of disease at the time of attending the clinic. We found no significant difference between the 2 treatment groups at weeks 4, 6, and 8 after beginning of treatment. (p > .05 Chi2).